GLP-1 RAs May Influence Development of Nonexudative AMD in Patients With Obesity

GLP-1 RA usage is associated with a reduction in risk of developing nonexudative age-related macular degeneration (AMD), according to a study comparing GLP-1 RAs, other weight-loss drugs (OWLDs), and no weight-loss medication use.¹

Research has…